Top 15 Biotech Angel Investors in Australia (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Mike Wallas
Angel
|
2 | Australia | Seed | Video, Water, Biotechnology | |
|
Annie Hill
Angel
|
1 | Australia | Seed | Aquaculture, Life Science, Biotechnology | |
|
Stephen Ho
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Catherine Lacavera
Angel
|
1 | Canada, Australia, United States | Seed, Pre-Seed | Medical, Robotics, Health Care | |
|
Daniel Petre
Angel
|
1 | Australia, Canada, United States | Seed, Series A, Series B | SaaS, Software, Health Care | $799k–$11M |
|
Benny Kleist
Angel
|
1 | Australia, New Zealand | Pre-Seed, Series A | Education, E-Learning, Life Science | |
|
Chadd Ciccarelli
Angel
|
1 | Australia, United States, New Zealand | Seed, Series A, Series B | Software, Food and Beverage, Information Technology | $605k–$1.5M |
|
Harry Debney
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Dennis Mehiel
Angel
|
1 | Australia | Series A | Life Science, Biotechnology, Venture Capital | |
|
Will Vicars
Angel
|
1 | Australia | Series A, Series B | Health Care, Neuroscience, Bioinformatics | |
|
Anton Borzov
Angel
|
1 | United States, Estonia, Ukraine | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $500k–$2.6M |
|
Richard Lipscombe
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Carl Stubbings
Angel
|
1 | Australia | Seed | Medical, Health Care, Biotechnology | |
|
Andrew O'Brien
Angel
|
1 | Australia | Pre-Seed | Biopharma, Health Care, Dietary Supplements | |
|
Artesian Investment
Angel
|
1 | United States, India, Australia | Pre-Seed, Seed, Series A | Artificial Intelligence, Agriculture, Information Technology | |
| Access all 27 angel investors in Australia Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Mike Wallas - Advisory Board @ Optifire Pty Ltd
Show more...Investment focus
- Industry: Video, Water, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Annie Hill
Show more...Investment focus
- Industry: Aquaculture, Life Science, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Fremantle Seaweed — Fremantle Seaweed is committed to combating climate change by growing Asparagopsis along with a variety of other local seaweeds ocean grown in local Western Australia waters.
Stephen Ho
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Catherine Lacavera is based out of Mountain View, California and is the Chief Legal Officer of Turing and Board of Directors at Toborlife AI. Catherine previously worked at ShipBob as Chief Legal Officer. Catherine Lacavera attended the University of Toronto. Catherine Lacavera has been awarded the Vanguard Award.
Show more...Investment focus
- Industry: Medical, Robotics, Health Care
- Stage:Seed, Pre-Seed
- Geography: Canada, Australia, United States
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
- HealthMatch — HealthMatch connects motivated patients to clinical trials and delivers EMR-verified, site-ready referrals to trial sites and sponsors.
- Toborlife AI — Toborlife AI, Robotic Solutions made easy with AI-integrated robot dogs and humanoids. Order a Unitree robot dog, get bonus accessories, and free shipping.
Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: Australia, Canada, United States
Investor stats
- Total investments: 8
- Round size: Seed $799k–$808k; Series A $6.5M–$11M; Series B $5M–$8.8M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Ento — Ento was founded in Australia in 2009 and provides one platform for HR, WFM and engagement. Since then we’ve become the chosen solution for over 3,000 workplaces across retail, hospitality, health, community, and more; rostering more than 30 million shifts for businesses ranging in size from 10 to 2,000+ staff.Our software is part of the nextgeneration of workforce management tools; cloud-based, accessible via a smartphone, tablet or desktop, and integrated with leading ATS, POS and payroll systems to provide a complete solution.
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Kismet — Find the best disability or healthcare service to support your journey
Benny Kleist is a Founder & COO of Eucalyptus.He attended The University of Queensland.
Show more...Investment focus
- Industry: Education, E-Learning, Life Science
- Stage:Pre-Seed, Series A
- Geography: Australia, New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
- NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
Chadd Ciccarelli
Show more...Investment focus
- Industry: Software, Food and Beverage, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 14
- Round size: Seed $605k–$1.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Triggr — Own Triggr.ai today. Secure checkout and guided transfer support. No hidden fees.
- Adatree — Adatree helps organisations unleash the potential of Open Banking and the CDR through turnkey Data Recipient and Data Holder solutions.
- AMASS Botanics — AMASS believes in the power of plants. From botanical beverages like Riverine Non-Alcoholic Spirit, Hard Seltzer, Dry Gin, and Vodka to cruelty-free Hand Sanitizer, Soap, Bath Salts, and natural soy wax Candles, we make clean botanics for social and self-care rituals. Free shipping on all orders over $50.
CEO @ Costa Group
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Dennis Mehiel is an American entrepreneur and investor, best known as the founder of Box USA. He has held leadership roles across business and public policy organizations and serves on the Board of Directors of the American Security Project.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Venture Capital
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Proto Axiom — Early-stage funding to growth capital, we guide scientific breakthroughs from proof-of-concept to commercial success. Our hands-on approach to support Australian research is a first-in-country model.
Will Vicars is a Chief Investment Officer at Caledonia.
Show more...Investment focus
- Industry: Health Care, Neuroscience, Bioinformatics
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Omniscient Neurotechnology — Pioneering the use of AI to decode the human brain.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Anton Borzov is the Product Designer at Neeva.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Estonia, Ukraine
Investor stats
- Total investments: 7
- Round size: Seed $500k–$2.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Liki24 — Liki24 is a logistics company that features a software platform that utilizes deep integration with partner pharmacies, clinics, and insurance companies. Its software is designed for logistics team coordination, task management, and data management.
- Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
- Puma Browser — Puma is a mobile browser and wallet for the Web3 ecosystem. Private by design. Today, we enable native IPFS, HNS & ENS support and seamless payments for creators, app & game developers via Coil and ILP. Long Term, our goal is to give 1b people access to the peer-to-peer and ownership based economy.
Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research).
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Carl Stubbings is the Chief Commercial Officer at Genetic Technologies Limited.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Managing Director & Founder @ vivaLAB
Show more...Investment focus
- Industry: Biopharma, Health Care, Dietary Supplements
- Stage:Pre-Seed
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- vivaLAB — Empowering you with health data to make your personal wellness experience better, tailored, and more vibrant
Artesian Investment
Show more...Investment focus
- Industry: Artificial Intelligence, Agriculture, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, India, Australia
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
- LYRO Robotics — A robotic packing solution for fruits and vegetables
- HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Biotech Angel investor funding in Australia at a glance
Stats across 24 deals from 27 investors.
Access all 27 angel investors in Australia Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 27 angel investors investing in Australia Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!